Aberrant VLA4 expression in MM cells enhances cell adhesion-mediated drug resistance by interacting with vascular cell adhesion molecule 1 (VCAM1) expressed in the BM stromal cells. Here, VCAM1 is linked to Miyoshi myopathy.